<p><strong>In the week from March 9, the following webinars await you in the field of atomic and molecular spectroscopy and spectrometry</strong></p><blockquote><h4><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinars"><strong>👉 DETAILS AND REGISTRATION IN THE WEBINARS SECTION</strong></a></h4><p><strong>👉 Search and filter in the largest global database</strong> with over <strong>5 500 GC, LC, MS and spectroscopy webinars</strong>.</p></blockquote><h5><strong>1. SelectScience: Supercharge LNP EE% and Size Characterization on Stunner AF</strong></h5><ul><li>Tu, 10.3.2026 17:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5988">Registration</a></li></ul><p>Discover a surfactant-free, single-instrument workflow to measure LNP size, payload, and encapsulation efficiency for RNA and pDNA in one assay using the Stunner AF platform.</p><h5><strong>2. Separation Science: Raman Spectroscopy for Li-ion Battery Material Diagnostics</strong></h5><ul><li>We, 11.3.2026 15:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5952">Registration</a></li></ul><p>This presentation explores Raman spectroscopy as a non-destructive, high-resolution diagnostic tool for characterizing electrode materials in lithium-ion batteries.</p><h5><strong>3. C&amp;EN: Explode into AI-Driven Automation with Stuntman</strong></h5><ul><li>We, 11.3.2026 16:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5989">Registration</a></li></ul><p>Discover how Stuntman embeds native AI into laboratory automation, translating scientific intent into executable experiments with automated design, execution, and data-driven iteration.</p><h5><strong>4. Anton Paar: Unlock Nanoparticle Analysis – Advanced DLS and Zeta Potential Solutions</strong></h5><ul><li>We, 11.3.2026 17:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5990">Registration</a></li></ul><p>Learn how the Litesizer DLS series enables precise particle size, zeta potential, and molecular mass measurements in a single platform for nanoparticle characterization.</p><h5><strong>5. Bruker: From Crude to Petrochemical Product – Enhancing Quality Control with Smarter XRF Solutions</strong></h5><ul><li>We, 11.3.2026 17:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5847">Registration</a></li></ul><p>Discover how XRF spectrometry enables rapid, standards-compliant elemental analysis for petrochemical processing and quality control.</p><h5><strong>6. Anton Paar: Polymer Rheology – Testing Behavior Across Time and Temperature</strong></h5><ul><li>We, 11.3.2026 17:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5799">Registration</a></li></ul><p>Learn how oscillatory rheology reveals polymer melt behavior beyond viscosity using techniques such as LVER analysis and frequency sweeps.</p><h5><strong>7. Metrohm: Full-Spectrum Raman for Research, Development, and Process Understanding</strong></h5><ul><li>We, 11.3.2026 19:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5966">Registration</a></li></ul><p>Discover how Metrohm i-Raman NxG and Duo provide molecular insight for APIs, polymers, and reaction monitoring with full-spectrum Raman coverage.</p><h5><strong>8. Agilent Technologies: Automation at the Next Level – Never Lose Track of Your Sample</strong></h5><ul><li>Th, 12.3.2026 06:30 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5965">Registration</a></li></ul><p>Learn how a fully digital laboratory environment can manage the entire sample lifecycle—from registration through chromatography workflows to reporting and secure archiving.</p><h5><strong>9. C&amp;EN: Microplastic Analysis in Water Using Vibrational Spectroscopy – Navigating ISO/FDIS 16094-2 Standards</strong></h5><ul><li>Th, 12.3.2026 11:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/webinar/5940">Registration</a></li></ul><p>Discover best practices for implementing ISO/FDIS 16094-2 for microplastics analysis using vibrational spectroscopy, including validation and quality control strategies.</p>

Webinars LabRulezICPMS Week 11/2026

<p><strong>This leaflet is intended as a comprehensive checklist outlining the key steps to consider when participating in a proficiency testing (PT) scheme. Selection of an appropriate PT scheme must be ensured [1]. It provides essential tips to help participants avoid common mistakes and achieve successful outcomes. The main stages of PT participation are covered, from receipt of PT items through to the review of received evaluations [1-3]. Documentation of outcomes for many of the topics addressed below is recommended, particularly for accreditation purposes.&nbsp;</strong></p><h4><strong>1. Prior to PT participation&nbsp;</strong></h4><ul><li>Verify that the PT provider has up-to-date billing, shipping and technical contact information for the laboratory.&nbsp;</li><li>Ensure that the laboratory has documented procedures in place or, if necessary, prepare procedures for: reviewing PT results upon receipt; taking corrective actions when assessments indicate poor performance; conducting periodic reviews of PT results over time; storing PT reports.&nbsp;</li></ul><h4><strong>2. Receipt of PT items&nbsp;</strong></h4><ul><li>Open the package of PT items immediately upon receipt to check their condition. Contact the PT provider and request a replacement if any PT items are missing, broken, leaking or otherwise compromised.&nbsp;</li><li>Study the PT provider’s instructions carefully to ensure they are clear and understandable (e.g. handling, storage, pre-treatment, preparation, reporting of results).&nbsp;</li><li>Register, identify, and mark the PT items according to normal procedures in the laboratory.&nbsp;</li><li>Store the PT items in accordance with any instructions provided.&nbsp;</li></ul><h4><strong>3. Measurements&nbsp;</strong></h4><ul><li>Read the instructions supplied by the PT provider carefully before starting the measurements.&nbsp;</li><li>Carry out the measurements under conditions as close as possible to routine testing, unless otherwise instructed by the PT provider.&nbsp;</li><li>Ensure that the analysis is carried out to meet any measurement deadline requirements.</li></ul><h4><strong>4. Reporting results&nbsp;</strong></h4><ul><li>Allow sufficient time for reporting the results to the PT provider.&nbsp;</li><li>Report all the information required by the PT provider.&nbsp;</li><li>Ensure that the results are reported in the requested format (e.g. units, number of significant figures, decimal places).&nbsp;</li><li>Ensure that the results you are going to submit are those that you intend, correcting for any identified transcription errors (e.g. mix-up of samples or analytes).&nbsp;</li><li>Confirm that the submission process of the results to the PT provider has been completed.&nbsp;</li></ul><h4><strong>5. Reviewing PT reports&nbsp;</strong></h4><ul><li>Read the PT report as soon as possible and check that your results and other information are correctly represented; report any errors immediately to the PT provider.&nbsp;</li><li>Take notice of any comments on the specific PT round, evaluation of performance, and other matters relevant to the results of the PT round which provide valuable context to your individual results.&nbsp;</li><li>Review your assessed performance carefully in accordance with your laboratory procedures.&nbsp;</li><li>Store the PT report according to internal procedures.&nbsp;</li></ul><h4><strong>6. Follow-up on participation in a PT scheme&nbsp;</strong></h4><ul><li>Investigate any poor performance in accordance with your laboratory quality system [4].&nbsp;</li><li>Evaluate the impact of poor performance (e.g. risk that poor quality data may have been reported to customers).&nbsp;</li><li>Implement any corrective actions as relevant, and if possible, make use of any surplus PT items [5] to assess effectiveness.&nbsp;</li><li>Monitor any trends in performance over time, concentration levels, etc.&nbsp;</li></ul><blockquote><p>Information about PT providers and PT schemes can be obtained from your national accreditation body, from the <a target="_blank" rel="noopener noreferrer" href="https://www.eptis.org/"><strong>EPTIS website</strong></a> or from other national or international organizations.</p></blockquote>

Basic instructions for participants in a proficiency testing scheme

<p><strong>Our Library never stops expanding. What are the most recent contributions to LabRulezICPMS Library in the week of 9th March 2026? Check out new documents from the field of spectroscopy/spectrometry and related techniques!</strong></p><blockquote><p><span style="font-size:20px;">👉 </span><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library"><span style="font-size:20px;"><strong>SEARCH THE LARGEST REPOSITORY OF DOCUMENTS ABOUT SPECTROSCOPY/SPECTROMETRY RELATED TECHNIQUES</strong></span></a></p></blockquote><blockquote><p><strong>👉 Need info about different analytical techniques?</strong> Peek into <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/library"><strong>LabRulezLCMS</strong></a> or <a target="_blank" rel="noopener noreferrer" href="https://gcms.labrulez.com/library"><strong>LabRulezGCMS</strong></a> libraries.</p></blockquote><p>This week we bring you application notes by <strong>Agilent Technologies</strong>, <strong>Metrohm,</strong> <strong>Shimadzu </strong>and<strong> Thermo Fisher Scientific!</strong></p><h3><strong>1. Agilent Technologies: Spectral Transmission Measurements of Pharmaceutical Packaging</strong></h3><p><strong>Using the </strong><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library?mainauthorItems=10&amp;search=Cary+60+UV%E2%80%91Vis"><strong>Agilent Cary 60 UV‑Vis</strong></a><strong> Diffuse Reflectance Accessory following EP &lt;3.2.1&gt;, USP &lt;660&gt;, and USP &lt;661.2&gt;</strong></p><ul><li>Application note</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/labrulez-bucket-strapi-h3hsga3/an_pharmaceutical_packaging_transmission_cary_60_uv_vis_dra_5994_8889en_agilent_2c933e5576.pdf"><strong>Full PDF for download</strong></a></li></ul><p>Pharmaceutical containers play a significant role in maintaining final drug stability, integrity, and safety, from manufacturing to distribution to the end user. The ability of the packaging system to protect the drug from external agents is critical for quality assurance. Therefore, all pharmaceutical packaging systems must conform to stringent standards.&nbsp;</p><p>Plastic and glass are commonly used materials for packaging, and they are typically transparent or opaque. Transparency to ultraviolet (UV) light can pose a risk to light‑sensitive pharmaceuticals, as exposure can initiate adverse—and sometimes harmful—photochemical reactions that can significantly affect drug quality and reduce shelf-life.<sup>1</sup>&nbsp;</p><p>The EP and USP define well-established standards, designed to measure physiochemical and functional properties of packaging components intended to contain a drug product (pharmaceutical containers), to meet regulatory requirements. The EP Chapter &lt;3.2.1&gt; Glass Containers for Pharmaceutical Use includes a functionality test method to demonstrate adequate light resistance of colored glass containers through spectral transmission measurement. An included acceptance criterion specifies the allowed maximum amount of light transmitted by the tested material, defined by the drug product dosage administration form. For example, for glass containers that package oral drug products, the acceptance criterion defines that the observed spectral transmission should not exceed 10% at any wavelength in the range of 290 to 450 nm (&lt; 10%T).<sup>2</sup> The identical test and criterion are found in USP Chapter &lt;660&gt; Containers – Glass.<sup>3</sup> In addition, the USP Chapter &lt;661.2&gt; Plastic Packaging Systems for Pharmaceutical Use also includes the analogous functionality test method and acceptance criterion for plastic pharmaceutical packaging.<sup>4&nbsp;</sup></p><p>The <a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library?mainauthorItems=10&amp;search=Cary+60+UV%E2%80%91Vis"><strong>Cary 60 UV-Vis spectrophotometer</strong></a>, equipped with the Cary 60 UV-Vis DRA, was chosen for measurement due to its extended ability to reliably measure precise transmission of scattering materials (Figure 1). The Cary 60 UV-Vis is a versatile spectrophotometer; however, measuring materials like plastics and glass, which are textured, translucent, or opaque in a manner that scatters light can result in challenges in satisfactorily measuring light transmittance with standard techniques. In a standard spectrophotometer, scattering materials tend to diffuse transmitted light, deviating an unquantifiable amount of light from the direct optical path of the detector. The detector may not collect all the scattered (lost) light, resulting in inaccurate measurements and results.&nbsp;</p><p>For this reason, the Cary 60 UV-Vis was equipped with an internal DRA, which uses a 50 mm integrating PTFE-coated sphere that easily sits inside the spectrophotometer's sample compartment. For these applications, using a DRA can optimize light collection. The sphere's design captures all scattered light uniformly, overcoming scattering losses for accurate measurement of transmitted light. In applications where total transmission is crucial for quality assurance, the DRA is an essential tool for accurate measurements.</p><h4><strong>Conclusion&nbsp;</strong></h4><p>In this application note, an Agilent Cary 60 UV-Vis spectrophotometer, fitted with an Agilent Cary 60 UV‑Vis DRA, was used to reliably and quickly determine the spectral transmission of packaging systems used for pharmaceuticals, following the EP &lt;3.2.1&gt;, USP &lt;660&gt;, and USP &lt;661.2&gt; test methods for functionality of light-resistant packaging systems. The integrating sphere enabled the instrument to accurately measure total transmittance of plastic and glass (scattering) materials.&nbsp;</p><p>All containers presented less than the defined maximum %T specification, demonstrating light-resistance functionality for containing light-sensitive drug products for oral administration. This method illustrates the importance of accurate testing for quality assurance of pharmaceutical packaging. The Agilent Cary 60 UV-Vis spectrophotometer, paired with Cary WinUV Pharma software, delivers secure data management and compliance for regulated pharmaceutical labs.</p><h3><strong>2. Metrohm: Multiparameter hops analysis by near-infrared spectroscopy (NIRS)</strong></h3><p><strong>Rapid determination of alpha acids, beta acids, cohumulone content, total oil content, HSI, and moisture</strong></p><ul><li>Application note</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/labrulez-bucket-strapi-h3hsga3/an_nir_130_download_6177b89ee1.pdf"><strong>Full PDF for download</strong></a></li></ul><p>The quality of hops and hop pellets is vital across the entire brewing supply chain. Traditional methods used for quality control (e.g., titration and HPLC) are highly accurate and widely accepted. They are also time consuming, labor intensive, and dependent on chemical reagents which not only incur ongoing material costs but also require careful handling and proper disposal. Near-infrared spectroscopy (NIRS) offers a compelling alternative when ultra-high precision is not necessary. It enables the rapid analysis of multiple parameters within a minute without using any chemicals. This Application Note outlines the measurement setup and the results of cohumulone, hop oils, and moisture content, the hop storage index (HSI), and hops acids analysis with NIRS.</p><h4><strong>EXPERIMENTAL EQUIPMENT&nbsp;</strong></h4><p>More than 500 fresh hop samples and ground hop pellets were analyzed on an <a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library?mainauthorItems=220&amp;search=omnis+nir"><strong>OMNIS NIR Analyzer Solid</strong></a> (Figure 1). The samples were added to an OMNIS sample cup and analyzed in diffuse reflection mode. To include sample variety, the sample rotated during measurement to collect spectra from different locations. The automatically averaged spectra were used for model development. Spectra acquisition, model development, and validation were carried out with the OMNIS Software.&nbsp;</p><p>Reference values for alpha acids were obtained using various official methods, including EBC 7.4, EBC 7.5, and EBC 7.7. Total oils and beta acid content were determined using EBC 7.4, while EBC 7.7 was employed for cohumulone analysis. Moisture content and the hop storage index (HSI) were measured using a halogen moisture analyzer and a UV-VIS photometer, respectively.</p><h4><strong>CONCLUSION</strong></h4><p>This Application Note demonstrates the feasibility of using NIR spectroscopy for the analysis of freshly harvested hops and ground hop pellets to determine cohumulone, moisture, and total oil content, HSI, and alpha and beta acids. Using alpha acids as an example, the difference between a prediction model covering the full concentration range and a model specific to a narrower range was highlighted. The latter reduced the prediction error by a factor of two.&nbsp;</p><p>Users can apply this approach to maximize accuracy. In the OMNIS Software, both models can be combined to automatically perform the following sequence. First, the alpha acid concentration is estimated using the broad-range model; then, a more precise prediction is made using the restricted-range model.</p><h3><strong>3. Shimadzu: Observation of Acrylic Block Fracture during Impact Compression Using the Hopkinson Bar Method</strong></h3><ul><li>Application note</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/labrulez-bucket-strapi-h3hsga3/an_01_01146_en_dc42e77a9c.pdf"><strong>Full PDF for download</strong></a></li></ul><h4><strong>User Benefits</strong></h4><ul><li>The HPV -X3 offers three times the resolution of conventional models, enabling observation of specimen fracture at much higher resolution.</li><li>With a maximum frame rate of 20 Mfps, the HPV-X3 is well-suited for observing high-speed phenomena such as an impact test</li></ul><p>Understanding materials properties is critical to product design. In particular, for applications such as transportation equipment, where materials may be subjected to impact loads, it is essential to evaluate not only static properties but also impact properties. When subjected to impact, materials may exhibit stress and strain characteristics different from those under static loading, making it essential to quantify these characteristics through impact testing.&nbsp;</p><p>The Hopkinson bar method is a well-established technique for impact compression testing. Proposed by B. Hopkinson, this method enables detailed analysis of a material’s impact response and evaluation of its fracture properties by subjecting the specimen to a sudden force using a bar-launching device. This paper presents an example of an impact compression test on an acrylic specimen with a central circular hole, recorded with an HPV-X3 high-speed video camera (Fig. 2) using the Hopkinson bar method.</p><h4><strong>Imaging System&nbsp;</strong></h4><p>The imaging devices are listed in Table 1, and the imaging conditions are listed in Table 2. As shown in Fig. 4(b), laser illumination was directed from the rear of the specimen toward the lens, and imaging was performed with the <a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library?mainauthorItems=1&amp;search=HPV-X3"><strong>HPV-X3</strong></a> using a close-up ring, bellows, and macro lens. This setup enabled observation of the fracture process in the acrylic block. Two types of imaging were conducted: observation of crack propagation immediately after loading, and observation of subsequent fracture.</p><h4><strong>Conclusion&nbsp;</strong></h4><p>The impact compression test of an acrylic specimen using the Hopkinson bar method was observed using the HPV-X3 highspeed video camera. Inside the compressed specimen, the propagation of a wavefront believed to be a stress wave was first observed. Subsequently, cracks propagated from the central circular hole toward the left and right surfaces, and finally, diagonal cracks formed, leading to complete fracture. The progress of this series of fracture processes was clearly captured.&nbsp;</p><p>The HPV-X3 has three times the resolution of the previous <a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library?mainauthorItems=1&amp;search=HPV-X2"><strong>HPVX2 model</strong></a>, enabling more detailed observation of specimens during impact tests, including the Hopkinson bar method. Furthermore, because fracture phenomena during impact testing occur at high speeds, the HPV-X3, which can record images at up to 20 Mfps, is ideal for capturing them.</p><h3><strong>4. Thermo Fisher Scientific: Analysis of silica in air filters using ARL X’TRA Companion X-ray Diffractometer</strong></h3><ul><li>Application note</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/labrulez-bucket-strapi-h3hsga3/analysis_of_silica_in_air_an41521_a3b8eb33d5.pdf"><strong>Full PDF for download</strong></a></li></ul><p>The analysis of silica in air filters is a critical aspect of occupational health and safety, aimed at protecting workers from the harmful effects of inhaling crystalline silica particles, which can lead to diseases such as silicosis and lung cancer. The NIOSH 7500 method (NIOSH, 2003) provides a detailed and standardized procedure for the determination of crystalline silica in air samples using X-ray diffraction (XRD). This method involves the collection of air samples on filters, which are then analyzed to identify and quantify the crystalline silica phases, including quartz, cristobalite, and tridymite.&nbsp;</p><p>XRD is chosen for its high specificity and sensitivity in distinguishing different crystalline forms of silica, making it a reliable analytical technique. The method outlined in NIOSH 7500 requires meticulous sample preparation, including the proper collection and handling of air filters, calibration with known standards, and strict adherence to analytical parameters to ensure accurate and reproducible results. Following the NIOSH 7500 norm and equivalent standards helps ensure the reliable monitoring of workplace air quality, thereby safeguarding workers’ health. The use of XRD in analyzing silica in air filters is an essential component of industrial hygiene and environmental monitoring programs, facilitating the detection and control of hazardous silica exposure in occupational settings.</p><h4><strong>Instrument and software&nbsp;</strong></h4><p>The <a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/products/2296"><strong>Thermo Scientific™ ARL™ X’TRA Companion X-ray Diffractometer</strong></a> (c.f. Figure 1) is a simple, easy-to-use benchtop XRD instrument for routine phase analysis as well as more advanced applications. The ARL X’TRA Companion XRD uses a θ/θ goniometer (160 mm radius) in Bragg-Brentano geometry coupled with a 600 W X-ray source (Cu or Co). The radial and axial collimation of the beam is controlled by divergence and Soller slits, while air scattering is reduced by a variable beam knife. An integrated water chiller is available on demand. Thanks to the innovative solid state pixel detector (55 x 55 μm pitch), the ARL X’TRA Companion XRD provides very fast data collection and comes with one-click Rietveld quantification capabilities and automated result transmission to a LIMS (laboratory information management system).</p><h4><strong>Your benefits&nbsp;</strong></h4><p>The ARL X’TRA Companion XRD provides data perfectly suited to quantify respirable quartz in air filters. Utilizing a calibration curve in a one-click refinement delivers results within minutes, ensuring ease-of-use for operators and reducing training requirements. XRD analysis of air filter samples complies with the NIOSH 7500 standard.</p>

News from LabRulezICPMS Library - Week 11, 2026

Article

Webinars

Application

Science and research

Eurachem is a European network promoting international traceability of chemical measurements and good analytical practice. It provides expert guidance, supports method validation, uncertainty evaluation, proficiency testing, and facilitates discussion on technical and policy issues in analytical quality.

Eurachem

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

Mettler-Toledo

Agilent Technologies

Bruker

Thermo Fisher Scientific

SelectScience

SciY/Mestrelab Research

<p><strong>Agilent Raman spectrometers use proprietary spatially offset Raman spectroscopy (SORS) and transmission Raman spectroscopy (TRS) in pharmaceutical raw material verification and quality control.&nbsp;</strong></p><p>SORS enables our Raman spectrometers to analyze through containers and opaque barriers, from helping first responders identify the contents of suspect packages, to high-throughput raw material identification inside unopened packaging at pharmaceutical quality control. TRS nondestructively screens whole tablets and capsules in seconds, for rapid content uniformity and polymorph analysis in pharma QC and formulation development</p><blockquote><p><strong>Presenter: </strong>Yanqia Wang, PhD (Application Engineer, Molecular Spectroscopy, Agilent Technologies, Inc.)</p><p>Dr. Yanqia Wang started working for Agilent Technologies Inc. as a FTIR application Engineer in 2013, providing pre-&amp;post-sale application support. The products he covers from Bench-top FTIR microscopes to various Mobile FTIR spectrometers. Dr. Wang received his PhD of analytical chemistry from Duke University in 2004, doing dynamic IR spectroscopy research. Then he joined Fitzpatrick Center for Photonics at Duke University, doing Tissue Raman spectrometer instrumentation. Since 2007, Dr. Wang worked for Avery Dennison Corp. as a spectroscopist, providing molecular analytical support to the research &amp; development.</p></blockquote><p>&nbsp;</p>

Agilent Technologies: Raman Spectroscopy for Pharmaceutical Applications

Raman Spectroscopy for Pharmaceutical Applications

Agilent Raman spectrometers use proprietary SORS and TRS in pharmaceutical raw material verification and quality control

<header><p><strong>Determining the Influence of Water on Solid Materials by TGA-, TMA-, and DMA-Sorption</strong></p></header><main><div><div><p><strong>Program události</strong></p><ul><li>Introduction to sorption and the effects of moisture content</li><li>Different sorption analyzer systems and sorption measurements</li><li>Relative humidity calibration</li><li>Practical application examples (TGA, TMA, DMA)</li><li>Interactive Q&amp;A</li></ul></div></div><div><div><p>The presence of moisture significantly influences material properties such as stability, shelf-life, and powder clumping. It can impact the effectiveness of drugs, affect the mechanical and physical properties of plastics, and cause microbial growth in foods. Understanding how different materials respond to moisture content is therefore critical, particularly for the food, polymer, and pharmaceutical sectors.</p><p>In our upcoming live webinar, we will explore sorption analysis using the thermal analysis techniques TGA, TMA, and DMA, providing you with valuable insights into how humidity and moisture impact material properties. Join us to enhance your knowledge and discover practical applications for your work!</p></div></div><div><div><div><h5><strong>The Advantages of Sorption Analysis by Thermal Analysis</strong></h5><p>Sorption analysis using TGA, TMA, or DMA offers significant advantages, including:</p><ul><li>Measuring material properties under precisely controlled relative humidity conditions</li><li>Clear insights into how moisture impacts the substance of interest</li><li>Determination of sorption enthalpies and calculation of key parameters such as isotherms, BET and GAB plots, and surface coverage behavior.</li></ul><p>These insights help you to make informed decisions in applications ranging from product formulation to quality control.</p><p>Register for our upcoming live webinar to learn more about these benefits and explore practical applications. The webinar will conclude with a <strong>live Q&amp;A session</strong>, so get your questions ready!</p><ul><li><span style="padding-right:0px;" id="webinar-session-1"><strong>20. 11. 2025 8:00,&nbsp; English&nbsp;</strong></span><span id="webinar-session-2"><strong><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"></svg></strong></span></li><li><span id="webinar-session-2"><strong>20. 11. 2025 16:00,&nbsp; English</strong></span></li></ul><blockquote><p><strong>Presenter: </strong>Nicolas Fedelich&nbsp;</p><p>With a background in chemical engineering, Nicolas joined METTLER TOLEDO in 2009 as an application specialist for Thermal Analysis. Before that, he gained expertise in different laboratories implementing, developing, and validating analytical methods in both the pharmaceutical and environmental fields. Nicolas also worked for three years in the field carrying out on-site customer training and providing expert thermal analysis application support. In his present position, Nicolas expertly uses, teaches, and supports DSC, TGA, TMA, and DMA instruments at the METTLER TOLEDO head office in Switzerland.</p></blockquote></div></div></div></main>

Mettler Toledo: Sorption Analysis by Thermal Analysis

Sorption Analysis by Thermal Analysis

Join our live webinar on sorption analysis with TGA, TMA, and DMA to explore the impact of humidity and moisture on material properties.

<div><p><strong>Despite great progress in the development of advanced in vitro models such as co-cultures, organ-on-a-chip, and microfluidic systems, in vitro models still lack the physiological complexity of a living organism regarding blood flow, metabolism, and endogenous membrane barriers. The use of fertilized chicken eggs (in ovo model) bridges the gap between cell-based assays and rodent models, rendering this model a useful tool for the initial evaluation of new radiotracers regarding their in vivo performance. Simultaneous PET/MRI offers great potential in terms of soft tissue contrast, as it enables clear differentiation between embryonic organs and tumor tissue, thus allowing very accurate assignment of the PET signal to embryonic structures.</strong></p><h4><strong>Webinar Overview</strong></h4><p>The chick embryo and its chorioallantoic membrane (CAM) have been used in biomedical research for centuries, leading to fundamental knowledge about the developing chick embryo and groundbreaking discoveries in cardiovascular and tumor biology. This webinar will showcase different applications of this model in preclinical imaging. The contribution of the in ovo model to the 3R principle in tracer development will be discussed. The experimental workflow, starting with the incubation and handling of fertilized chicken eggs, intravenous injections into CAM-vessels, immobilization of chick embryos, image acquisition, and quantification, will be illustrated. Challenges and potential disadvantages will be discussed, and practical advice will be given.</p><h5><strong>What to Expect</strong></h5><p>The webinar will discuss the contribution of the in ovo model to the 3Rs principle in tracer development and will provide guidance on how to perform in ovo PET/MR imaging.</p><h5><strong>Key Learning Points</strong></h5><ul><li>Simultaneous PET/MR of chick embryo and its chorioallantoic membrane (CAM)</li><li>Alternative imaging platform for faster &amp; cost-effective tracer development</li><li>Experimental procedures, advantages &amp; challenges</li></ul><h5><strong>Who should attend:</strong></h5><p>This webinar is of interest to researchers who are developing new radiotracers or contrast agents and are looking for faster and more cost-effective methods besides wanting to explore alternatives to current animal models in the context of the 3Rs.</p><blockquote><p><strong>Presenter:</strong> Dr. Theresa Balber (Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine - Medical University of Vienna, Austria)</p><p>Dr. Theresa Balber is a radiopharmacist and preclinical imaging scientist. Her main research interests are the development of new radiopharmaceuticals and advanced model systems (spheroids, patient-derived tumoroids, and in vivo models) to improve cancer diagnostics and therapy. To test the biodistribution and tumor-targeting properties of newly developed compounds, she established the in ovo model as an alternative to small animals at the preclinical imaging laboratory (PIL), Medical University of Vienna, and developed the respective imaging protocols for fertilized chicken eggs using microPET/MRI. She and her team generated CAM-xenografts based on human cancer cell lines, patient-derived glioma cells, and patient-derived colorectal cancer tumoroids, and tested radiolabeled small molecules, peptides, and antibodies for their distribution within the chicken embryo and tumor accumulation in the above-mentioned xenograft models.</p></blockquote></div>

Bruker: The Fertilized Chicken Egg as an Alternative Model In Tracer Development

The Fertilized Chicken Egg as an Alternative Model In Tracer Development

Explore in ovo PET/MRI for tracer development. Learn how chick embryos offer a 3Rs-compliant, efficient alternative to rodent models in preclinical imaging.

In Ovo PET/MRI: A 3Rs Model for Tracer Development

<div><p><strong>Nuclear Magnetic Resonance (NMR) spectroscopy is a vital tool for analyzing protein structure and function. Unlike traditional biophysical methods, NMR enables the study of proteins in their natural and dynamic states with greater sensitivity and detailed information.&nbsp;</strong></p><p>This presentation will highlight current NMR techniques and compare them to conventional methods for characterizing protein therapeutics. Using NMR in regulatory processes strengthens drug characterization and supports adherence to regulatory standards. As biopharmaceuticals advance, NMR's role in drug development and approval will become increasingly important.</p><h4><strong>Key Learning Points</strong></h4><ul><li><strong>Protein Therapeutics Characterization:</strong> Learn about how NMR methods used in comprehensive protein analysis are applied from early development through to market approval.</li><li><strong>Characterization of Protein Therapeutics in Regulatory Submissions:</strong> Explore how NMR deliver critical structural and functional data that can support regulatory filings, ensuring product quality and consistency.</li><li><strong>NMR in Regulatory Processes: </strong>Integrate the unique advantages of NMR to address challenging regulatory expectations and supporting successful filling of biopharmaceuticals.</li></ul><h4><strong>What to Expect</strong></h4><ul><li>Gain practical insights into how Nuclear Magnetic Resonance (NMR) is advancing the characterization of protein therapeutics for regulatory submissions. This webinar will address how NMR based method can be used to support the detection and comparison of high order structure of protein therapeutics and report potential deviations.</li></ul><h4><strong>Who should attend?</strong></h4><ul><li>This webinar is ideal for scientists and biopharma leaders working on protein therapeutics characterization, experts in biotherapeutics development and bioprocessing specialists. Anyone involved in advanced characterization techniques, including those involved in bioprocess development and/or those supporting regulatory filling will benefit from the session.</li></ul><blockquote><p><strong>Presenter:</strong> Dr. Mats Wikstrom (Associate Director, Attribute Sciences, Amgen Inc.)</p><p>I possess extensive experience in research, development, and management within both academic institutions and the pharmaceutical industry. My career includes assignments at esteemed organizations such as Lund University (Sweden), the National Institutes of Health (NIH) (United States), Pharmacia and Upjohn Company (Sweden/United States), Biovitrum Company, Karolinska Institute (Sweden), University of Copenhagen (Denmark), and Amgen Inc (United States). Presently, I lead the Protein and Synthetics Characterization group at Amgen Inc, Thousand Oaks, United States, where my group provides structural characterization support for the development and marketing of Amgen’s synthetic and biopharmaceutical products.</p><p><strong>Moderator: </strong>Dr. Martial Piotto (Pharma product manager of Biologics solutions)</p><p>Martial Piotto obtained his Ph.D. in NMR spectroscopy at the University of Purdue, USA (Pr. D. Gorenstein). He then joined Bruker France as head of NMR application where he worked on various aspects of NMR spectroscopy, notably the development of new pulse sequences and HRMAS technology. Over the years, he grew an interest in applications of NMR in the pharmaceutical and medical fields. His work currently focusses on the characterization of Biologics (mAb, vaccines and therapeutic oligonucleotides) by combining NMR and multivariate statistical tools.</p></blockquote></div>

Bruker: Deploying NMR for the Product Characterization of Protein Therapeutics in Regulatory Submissions

Deploying NMR for the Product Characterization of Protein Therapeutics in Regulatory Submissions

Discover how NMR supports regulatory protein analysis with high-order structure insights, improving quality, consistency, and approval of biopharmaceuticals.

NMR Applications in Protein Therapeutic QC

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div><p><strong>Imaging flow cytometry (IFC) has emerged as a powerful approach for single extracellular vesicle (EV) characterization, yet its broader adoption has been hindered by challenges in assay standardization and data comparability. Join Dr. Wouter W. Woud, Senior Scientist at ExoVectory, as highlights recent methodological advances addressing these limitations. Building on earlier work that established workflows for direct detection and phenotyping of EVs in unprocessed plasma, current efforts focus on developing rigorous calibration strategies for IFC.</strong></p><p>Recent work has introduced bead-based size calibration and fluorescence intensity standardization, enabling instrument-specific signals to be expressed in quantitative units. These approaches markedly improve reproducibility across different platforms and laboratories, thereby supporting cross-study comparability. Standardized IFC data further provide a framework for quantitative analyses in both fundamental EV research and the quality assessment of vesicle-based therapeutics.</p><p>Together, these methodological advances position IFC as a calibrated, quantitative platform for nanoparticle cytometry, with the potential to accelerate both biomarker discovery and translational applications in extracellular vesicle science.</p><h4><strong>Topics discussed in this webinar will include:</strong></h4><ul><li>Advances in EV assay standardization and data comparability</li><li>Development of calibration strategies for IFC</li><li>Introduction of bead-based standardization methodology for quantitative EV analyses</li></ul><h4><strong>Who should attend?</strong></h4><ul><li>Researchers using IFC who are currently or wish to perform small particle analysis</li><li>Anyone interested in flow cytometry applications and small particle analysis</li></ul><h5><strong>Certificate of attendance</strong></h5><ul><li>If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.</li><li>If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.</li></ul><blockquote><p><strong>Presenter: </strong>Dr. Wouter W. Woud (Senior Scientist, ExoVectory)</p><p>Dr. Wouter W. Woud is an expert in nanoparticle flow cytometry, with a particular focus on imaging flow cytometry for the study of extracellular vesicles. Wouter obtained his Ph.D. at the Rotterdam Transplant Institute, Erasmus MC, The Netherlands, where he developed an imaging flow cytometry-based method to detect and characterize single vesicles directly in human plasma. His doctoral thesis, “Fantastic vesicles and how to find them” (2023), outlined best practices for instrument calibration, assay design, and data analysis, helping to establish imaging flow cytometry as a reliable tool for vesicle research.</p><p>During his Ph.D. studies, Dr. Woud demonstrated how imaging flow cytometry can uncover clinically relevant vesicle populations without the need for complex pre-isolation steps. More recently, he helped introduce calibration methods that make results comparable across different instruments, an important step toward standardized, reproducible measurements.</p><p>Currently, Dr. Woud is a Senior Scientist at ExoVectory, a company advancing EV-based therapeutics. There, he leads efforts to apply calibrated imaging flow cytometry for product characterization, ensuring quality, potency, and stability. By bridging academic innovation with industry needs, Dr. Woud is helping move EV science toward real-world therapeutic applications.</p><p><strong>Moderator:</strong> Matilde Marques (Life Sciences Assistant Editor, SelectScience)</p></blockquote></div></div></div>

SelectScience: Size and fluorescence calibrated imaging flow cytometry: From arbitrary to standardized units

Size and fluorescence calibrated imaging flow cytometry: From arbitrary to standardized units

Discover new IFC calibration and standardization methods improving reproducibility and quantitative EV analysis across platforms and labs.

Size and fluorescence calibrated imaging flow cytometry

<p><strong>Diffraction has long revealed the structure of matter — from Young’s double-slit experiment to Laue’s work with X-rays and crystals. In this webinar, experts from the University of Rome will explore how diffraction continues to advance modern mineralogy.</strong></p><h4><strong>Topics include:</strong></h4><ul><li>Fundamentals of powder X-ray diffraction (PXRD)</li><li>Sample preparation and diffraction pattern interpretation</li><li>Extracting meaningful information from PXRD data</li></ul><h4><strong>The session will also cover:</strong></h4><ul><li>Phase identification challenges, including asbestos detection</li><li>Quantitative analysis and amorphous phase evaluation in environmental studies</li></ul><p>To conclude, presenters will share a real-world case study on determining the structure of encapsulated organic UV filters using XRPD and Rietveld refinement.</p><p><strong>Complete the registration form to reserve your spot in the illuminating webinar.</strong></p><p>Moderated by Carlotta Giacobbe, Product Manager - X-ray diffraction, Thermo Fisher Scientific</p><blockquote><p><strong>Presenter:</strong> Giorgia Confalonieri, PhD (Tenure Track Researcher in Mineralogy and Crystallography)</p><p><strong>Presenter: </strong>Paolo Ballirano (Full Professor presso University of Rome "La Sapienza")</p></blockquote>

Thermo Fisher Scientific: Applied Mineralogy: Insights from Powder Diffraction

Applied Mineralogy: Insights from Powder Diffraction

In this webinar, experts from the University of Rome will explore how diffraction continues to advance modern mineralogy.

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div><p><strong>Join us for an insightful webinar designed for scientists and quality professionals working in protein synthesis and analysis. Dr. Jan Wuelfken will showcase how to accelerate your workflows and ensure compliance with cutting-edge analytical tools.</strong></p><h4><strong>Key learning objectives:</strong></h4><ul><li>Learn how Vaya Raman Spectroscopy enables rapid, non-destructive raw material identification to support efficient and compliant protein synthesis workflows.</li><li>Discover how the Cary 3500 UV-Vis spectrophotometer delivers high-throughput, precise protein quantification and characterization.</li><li>Gain practical insights into streamlining your analytical processes from raw materials to final protein products.</li></ul><h4><strong>Who should attend?</strong></h4><p>This webinar is tailored for professionals involved in protein synthesis and analysis, including analytical scientists, QC specialists, lab technicians, and researchers in biopharma and biotech. If you're looking to enhance raw material verification and streamline protein quantification workflows, this webinar will serve your needs.</p><blockquote><p><strong>Presenter:</strong> Jan Wülfken (Product Specialist, Raman Spectroscopy, Agilent Technologies)</p><p>Jan Wulfken graduated from the University of Hamburg in 1997, first with a diploma thesis about NMR-based conformation analysis of an antimicrobial peptide, and again in 2001 with his PhD thesis about developing CD4-binding peptides as inhibitors for HIV infection. He joined Varian, inc. in 2001 as a sales representative for molecular spectroscopy. With the acquisition of Varian in 2010 by Agilent, he took over the position of a product specialist for molecular spectroscopy in the Agilent International Distributor Organization (IDO). Today, his responsibility is the full Agilent molecular spectroscopy portfolio, including UV-Vis, UV-Vis/NIR, fluorescence, FTIR, and Raman spectroscopy, in IDO.</p></blockquote></div></div></div>

Agilent Technologies: Optimizing Biomolecular Quality Control - Addressing Manufacturing and Residue Analysis Challenges

UV-VIS and Raman Spectroscopy in BioPharma Protein Analysis

Boost protein analysis efficiency with Agilent’s Raman and UV-Vis tools. Learn to accelerate synthesis workflows and enhance compliance in your lab.

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div><p><strong>Join Agilent for an insightful webinar focused on quality control strategies for the release testing of biopharmaceutical drugs in alignment with USP protocols. Three expert speakers will explore critical analytical techniques: (U)HPLC for detecting and characterizing aggregate formation, ICP-MS for quantifying metal impurities, and GC/MS for analyzing residual solvents.&nbsp;</strong></p><h4><strong>Key learning objectives:</strong></h4><ul><li>This session will provide practical guidance and innovative solutions to ensure compliance and product safety in Biopharma QC workflows.</li></ul><h4><strong>Who should attend?</strong></h4><p>Whether you're an analytical scientist, technician, researcher, or quality control specialist, this webinar is designed to empower you with practical insights and cutting-edge techniques. Discover how to streamline your workflows, boost analytical precision, and ensure regulatory compliance. Don’t miss this opportunity to explore integrated solutions that help bring biopharmaceutical products to market—safely, efficiently, and confidently.</p><blockquote><p><strong>Presenter:</strong> Hans Christian Høiberg (HPLC Product Specialist, Agilent Technologies)</p><p>Hans Høibergis a product specialist in liquid chromatography at Agilent and has been working here for the past 6 years. He holds a PhD in Nanoscience from Aarhus University, with a focus on biopharmaceuticals. Hans is passionate about the characterization of biologicals, and is a part of Agilent’s European Biopharma focus team.</p><p><strong>Presenter: </strong>Raimund Wahlen (Atomic Spectroscopy Product Specialist, Agilent Technologies)</p><p>Raimund Wahlen is the atomic spectroscopy product specialist for Agilent Technologies in the UK and Ireland and is actively involved in delivering technology-based solutions to the Li-ion battery market. Before joining Agilent in 2009, Raimund was a self-employed training consultant delivering ICP-MS applications training across EMEA, North America and South Africa. Between 1999 and 2003, Raimund worked as a Research Specialist at LGC Ltd in Teddington, UK with the focus of developing high-accuracy methods for analysis of organometallic species by LC, GC, and ICP-MS, which were used for the certification of new organometallic speciation reference materials.</p><p><strong>Presenter: </strong>Dr. Marion Schäffer (Product Specialist, GC and GC/MS, Agilent)</p><p>Marion Schäffer works as a product specialist for gas chromatography/mass spectrometry at Agilent Technologies in Germany. She has +15years of experience in analytical chemistry, joining Agilent in 2014 as an application engineer for GC/MS.</p></blockquote></div></div></div>

Quality Control in Focus: USP-Aligned Testing for Biopharmaceuticals

Join us for webinar focused on quality control strategies for the release testing of biopharmaceutical drugs in alignment with USP protocols. 

USP-Aligned Testing for Biopharmaceuticals

<div><p><strong>Throughout the 19th and 20th centuries, pesticides containing heavy metals such as arsenic, lead, mercury, and bromine were widely applied to protect museum collections. Today, these residues remain on objects, creating both health and conservation challenges—particularly for museum workers or items now subject to repatriation initiatives.</strong></p><p><strong>Micro-</strong> and also <strong>handheld X-ray fluorescence (XRF)</strong> spectroscopy is commonly used to study such substances, and qualitative identification often suffice. However, situations such as risk assessment, treatment planning, or collection surveys require quantitative data. Reliable concentration analysis is difficult because quantitative XRF analysis assumes homogenous samples, while pesticide residues usually form thin, uneven surface layers. Rather than a limitation, this can be addressed through adapted data interpretation.</p><p>This webinar will present practical approaches to quantifying residues in terms of mass deposition, supported by case studies on organic materials. The method combines standard addition with safe, self-made mock-ups mimicking pesticide deposits, enabling validation across diverse objects. By outlining best practices, limitations, and transferable workflows, this contribution provides conservators and heritage scientists new tools to extend XRF analysis beyond detection toward meaningful quantification.</p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Bruker_Cloth_with_varying_amounts_of_non_poisonous_K_Br_solution_d7d2aa32a8.jpg" alt="Bruker: Cloth with varying amounts of non-poisonous KBr solution used for creating calibration curves for quantitative analysis: (a) VIS; (b) Br-Kα distribution, M6 JETSTREAM, 50 kV, 600 µA, 40 µm spot, 300 µm pixel, 50 ms/px, 2x 60 mm2 SDD." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Bruker_Cloth_with_varying_amounts_of_non_poisonous_K_Br_solution_d7d2aa32a8.jpg 245w," sizes="100vw" width="957" height="462"></p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Bruker_Oak_wood_mock_ups_52e3fb69d1.jpg" alt="Bruker: Oak wood mock-ups with varying amounts of non-poisonous KBr solution to study penetration properties of pesticides in wood: (a) VIS; (b) Br-Kα, variation of amount at same concentration; (c) Br-Kα, varying concentration at same amount; (d) Cross-section through application. M4 TORNADO, 50 kV, 600 µA, 20 µm spot, 60 µm pixel, 10 ms/px, 2x 60 mm2 SDD." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Bruker_Oak_wood_mock_ups_52e3fb69d1.jpg 245w," sizes="100vw" width="981" height="598"></p><h4><strong>Who should watch?</strong></h4><ul><li>Heritage and Conservation Scientists</li><li>Collection care</li><li>M4 TORNADO, M6 JETSTREAM, CRONO, and ELIO and IRIS users</li></ul><blockquote><p><strong>Presenter:</strong> Dr. Mareike Gerken (Application Scientist, Bruker AXS)</p><p><strong>Presenter:</strong> Dr. Roald Tagle (Global Manager Application Science, Bruker AXS)</p></blockquote></div>

Bruker: Quantifying Historic Pesticide Residues on Collections: Practical Approaches with micro-XRF

Quantifying Historic Pesticide Residues on Collections: Practical Approaches with micro-XRF

Discover XRF-based methods for quantifying heavy metal pesticide residues on museum artifacts. Practical tools for conservators and heritage scientists.

Historic Pesticide Residues by micro-XRF

<p><strong>Content uniformity and assay are critical quality attributes for solid oral dosage forms, yet traditional wet chemistry methods are time consuming and destructive. In this webinar, we’ll showcase the automated SciYbotic Tablet Testing (TT) system that enables faster, more accurate non-destructive testing for tablet release.</strong></p><p>The system showcases a fully automated workflow for tablet quality testing that integrates robotic handling, 3D vision, and spectroscopic analysis with the Bruker Multi Purpose Analyzer (MPA) to eliminate manual variability and enhance precision. By aligning with Process Analytical Technology (PAT) and Pharma 4.0 goals, the SciYbotic TT enables real-time predictions of API content. It supports efficient, compliant tablet release, demonstrating the transformative impact of automation in pharmaceutical manufacturing.</p><h4><strong>Learning Points</strong></h4><ul><li>You’ll discover how the SciYbotic Tablet Testing (TT) system enables non-destructive, real-time analysis of content uniformity and assay.&nbsp;</li><li>Explore the integration of robotic handling, 3D vision, and spectroscopic analysis by Bruker MPA in a fully automated workflow.&nbsp;</li><li>Learn how the system aligns with PAT and Pharma 4.0 initiatives.&nbsp;</li><li>See how automation enhances precision, compliance, and efficiency in tablet release processes.&nbsp;</li></ul><h4><strong>Who should attend</strong></h4><ul><li>Oral Solid Dose (OSD) manufacturing professionals seeking to modernize quality control.&nbsp;</li><li>Quality assurance and quality control specialists focused on improving tablet release workflows.&nbsp;</li><li>Senior managers, process engineers and automation leads exploring Pharma 4.0 solutions and technology transfer.&nbsp;</li><li>PAT and advanced control strategy experts and leaders.&nbsp;</li></ul><blockquote><p><strong>Presenter:</strong> Andrew Anderson (Consultant)</p><p>Andrew Anderson is a strategic pharma leader with extensive expertise in small molecule development and advanced analytical technologies. At GSK and Johnson &amp; Johnson, he led the technology strategy, roadmaps, automation, and Process Analytical Technology (PAT) across R&amp;D and commercial operations. Recognized for forging impactful government, academic, and cross-pharma partnerships, Andrew promotes innovation through cross-functional leadership and comprehensive tech implementation, delivering measurable improvements in efficiency, data integrity, and resource optimization.</p><p><strong>Presenter: </strong>Matt Jones (Account Manager, SciY)</p><p>Matt Jones is a seasoned automation specialist with over 20 years of experience delivering engineered solutions across highly regulated sectors, including pharmaceuticals, biotechnology, and advanced manufacturing. His work frequently involves the application of process analytical technology (PAT) within custom automation systems designed to meet stringent industry standards.<br>With a strong foundation in vision systems and robotics engineering, Matt has deep expertise in machine integration, control architecture, and data-driven process optimization. He excels at translating complex requirements into scalable, compliant automation platforms that enhance throughput, quality, and traceability.</p><p><strong>Presenter: </strong>Holger Lutz (Business Unit Manager Chemistry, Pharma &amp; Process Applied Spectroscopy - Bruker Optics GmbH &amp; Co. KG)</p><p>PhD in Chemistry at University of Karlsruhe, Germany, focus on Analytical Chemistry. Starting 2002 as a NIR sales person at Bruker Optics. In 2007, took over the sales responsibility of PAT solutions in Germany. In parallel, built up a global sales and support infrastructure for PAT. Since 2018, is business unit manager of the newly created business unit “Chemistry, Pharma &amp; Process”. In this function, is involved in the product management of the new PAT analyzers and related software, supports the global sales &amp; application team, and is the main contact for Key Accounts.</p></blockquote>

SciY: Tablet Release Reinvented: Robotics, Vision, and Spectral Intelligence

Tablet Release Reinvented: Robotics, Vision, and Spectral Intelligence

Learn how automated robotic, vision, and spectroscopic workflows streamline non-destructive tablet testing, compliance, and Pharma 4.0 readiness.

Related content

News from LabRulezICPMS Library - Week 11, 2026

Basic instructions for participants in a proficiency testing scheme

Webinars LabRulezICPMS Week 11/2026